AnalystsMichael OkunewitchMichael Okunewitch's Stock Forecasts
AnalystsMichael Okunewitch
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4025 out of 4337 analysts
Average Return
-39.95%
Win Rate
9%1 out of 11
Risk vs Reward
Poor
Good
Michael Okunewitch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lexaria Bioscience CorpLEXX | +4.05% | $0.87 | $0.90 | 2023-07-21 - 2023-09-25 | Strong Buy |
Michael Okunewitch Analyst Color
Get additional color on Michael Okunewitch's coverage of popular stocks
Michael Okunewitch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Anebulo Pharmaceuticals IncANEB | 1 | Strong Buy | $6.00 | +83.49% | Initiates Coverage On | 5 days ago |
Lexaria Bioscience CorpLEXX | 1 | Strong Buy | $2.00 | +122.22% | Initiates Coverage On | 2 months ago |
Alzamend Neuro IncALZN | 1 | Strong Buy | $1.50 | +581.82% | Initiates Coverage On | 5 months ago |
Kiora Pharmaceuticals IncKPRX | 2 | Strong Buy | $12.00 | +2,159.89% | Upgrades | 8 months ago |
Mediwound LtdMDWD | 1 | Strong Buy | $25.00 | +191.34% | Initiates Coverage On | 9 months ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $6.00 | +292.16% | Initiates Coverage On | a year ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Longeveron IncLGVN | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 2 years ago |
Seqll IncSQL | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 2 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Citius Pharmaceuticals IncCTXR | 1 | Strong Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.